This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Its chiral structure makes it valuable for producing enantiomerically pure compounds, which are often essential for achieving desired therapeutic effects and minimizing side effects. Additionally, it is employed in research and development for exploring new pharmacological agents, especially those involving modulation of neurotransmitter systems. Its fluorine-containing structure also enhances metabolic stability and bioavailability of the resulting drugs.